211 related articles for article (PubMed ID: 32317171)
1. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
2. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Zhang Y; Chen H; Chen S; Li Z; Chen J; Li W
Oncoimmunology; 2021; 10(1):1957605. PubMed ID: 34377596
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
[TBL] [Abstract][Full Text] [Related]
5. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
Dixon SC; Nagle CM; Wentzensen N; Trabert B; Beeghly-Fadiel A; Schildkraut JM; Moysich KB; deFazio A; ; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Ness RB; Edwards RP; Jensen A; Kjær SK; Høgdall E; Berchuck A; Cramer DW; Terry KL; Poole EM; Bandera EV; Paddock LE; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Webb PM
Br J Cancer; 2017 Apr; 116(9):1223-1228. PubMed ID: 28350790
[TBL] [Abstract][Full Text] [Related]
6. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.
Nagle CM; Ibiebele TI; DeFazio A; Protani MM; Webb PM;
Cancer Epidemiol; 2015 Apr; 39(2):196-9. PubMed ID: 25666512
[TBL] [Abstract][Full Text] [Related]
7. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
8. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
9. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
Gronich N; Rennert G
Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
[TBL] [Abstract][Full Text] [Related]
10. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
11. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada.
Hanley GE; Kaur P; Berchuck A; Chase A; Grout B; Deurloo CM; Pike M; Richardson J; Terry KL; Webb PM; Pearce CL
Gynecol Oncol; 2021 Aug; 162(2):461-468. PubMed ID: 34090707
[TBL] [Abstract][Full Text] [Related]
13. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Cho MH; Yoo TG; Jeong SM; Shin DW
Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
[TBL] [Abstract][Full Text] [Related]
14. Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
Majidi A; Na R; Jordan SJ; De Fazio A; Webb PM;
Int J Cancer; 2021 Apr; 148(7):1608-1615. PubMed ID: 33034053
[TBL] [Abstract][Full Text] [Related]
15. Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer.
Gonzalez R; Gockley AA; Melamed A; Sugrue R; Clark RM; Del Carmen MG; Growdon W; Berkowitz RS; Horowitz NS; Worley MJ
Gynecol Oncol; 2020 Jun; 157(3):700-705. PubMed ID: 32222327
[TBL] [Abstract][Full Text] [Related]
16. Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review.
Li H; Zhang L; Yang F; Zhao R; Li X; Li H
Front Immunol; 2023; 14():1218386. PubMed ID: 37841249
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
18. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
[TBL] [Abstract][Full Text] [Related]
19. Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.
Hannibal CG; Dehlendorff C; Kjaer SK
Gynecol Oncol; 2018 Dec; 151(3):513-518. PubMed ID: 30249529
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]